In this guest editorial, Jon Sherlock, Senior Director, Product Management at Thermo Fisher Scientific explores why supporting laboratory professionals is the key to bridging the gap between innovation and patient outcomes
At-home self-collection reduces significant barriers for unscreened or under-screened individuals
Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments
Minimally invasive blood test enables greater patient access to monitoring of neuroinflammatory status versus current standard of care methods
BIOFIRE SPOTFIRE introduces a simple, small and smart approach to mycoplasma detection, helping biopharmaceutical manufacturers strengthen quality control, accelerate decision-making, and protect patients
Dr. Barbara Jones, CEO of CLSI, discusses emerging resistance trends, the importance of updated breakpoints, and how CLSI continues to support laboratories navigating the evolving AMR landscape
Discover how free software can help design oligos for PCR assays, reducing guesswork and enabling creation of effective diagnostic assays
Toni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research
The cobas c 703 and cobas ISE neo analytical units deliver higher testing capacity and increased automation, helping to improve laboratory workflows and advance patient care
Guest editorial by Eric Pabon, MBA Senior Manager, Global Product Marketing Hematology, Beckman Coulter
Join the online session for practical solutions for accurate sampling, handling, and analysis
The test currently under development by MicrosensDx involves the detection of the oxidized form of a novel biomarker that indicates the risk of severe sepsis
The partnership is guided by a shared belief that engineering excellence ultimately serves one purpose: to improve patient care
SCCM 2026 presentation reports 19% reduction in sepsis mortality and double-digit operational improvements across four hospitals
Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases
StatLab and Thermo Fisher Scientific among those recognized
The new computational infrastructure supports Roche’s vision of building an AI-accelerated healthcare organization
The certification includes conformity assessment for near-patient testing, enabling its use outside traditional laboratories, directly at the point of care
Your trusted source for online, expert led clinical CE/CPD activities in 2026
The Elecsys ApoE4 test eliminates the need for confirmatory genetic testing in the significant proportion of Alzheimer’s patients who do not carry the ApoE4 variant
Novel RUO tests can help scientists understand neurological function and disease progression
Using just a few drops of blood from a finger prick, the test can help guide treatment decisions in 15 minutes – reducing unnecessary antibiotic use, detecting bacterial infections that may otherwise be missed, and ultimately improving patient outcomes
Brilliance Candida 2 Agar and Spectra Candida Agar support earlier detection, faster outbreak response and more informed treatment decisions in healthcare settings*
TacroType™ Pharmacogenetic Test designed to support more personalized tacrolimus dosing, assisting clinical decision-making in solid organ transplant recipients
The board is comprised of leading experts in cell-free DNA, oncology screening, and molecular diagnostics across research, development, and commercialization
